Bioactive compounds from endemic plants of Southwest Portugal: Inhibition of acetylcholinesterase and radical scavenging activities

References

• Adewusi EA, Moodley N, Steenkamp V. (2010). Medicinal plants with cholinesterase inhibitory activity: A review. Afr J Biotechnol, 9, 8257–8276.
   Google Scholar
• Andersen JK. (2004). Oxidative stress in neurodegeneration: cause or consequence? Nat Med, 10 Suppl, S18–S25.
   PubMed Web of Science ®Google Scholar
• Bachurin SO. (2003). Medicinal chemistry approaches for the treatment and prevention of Alzheimer’s disease. Med Res Rev, 23, 48–88.
   PubMed Web of Science ®Google Scholar
• Beking K, Vieira A. (2010). Flavonoid intake and disability-adjusted life years due to Alzheimer’s and related dementias: a population-based study involving twenty-three developed countries. Public Health Nutr, 13, 1403–1409.
   PubMed Web of Science ®Google Scholar
• Chung YK, Heo HJ, Kim EK, Kim HK, Huh TL, Lim Y, Kim SK, Shin DH. (2001). Inhibitory effect of ursolic acid purified from Origanum majorana L on the acetylcholinesterase. Mol Cells, 11, 137–143.
   PubMed Web of Science ®Google Scholar
• Eldeen IM, Elgorashi EE, van Staden J. (2005). Antibacterial, anti-inflammatory, anti-cholinesterase and mutagenic effects of extracts obtained from some trees used in South African traditional medicine. J Ethnopharmacol, 102, 457–464.
   PubMed Web of Science ®Google Scholar
• El-Hassan A, El-Sayed M, Hamed AI, Rhee IK, Ahmed AA, Zeller KP, Verpoorte R. (2003). Bioactive constituents of Leptadenia arborea. Fitoterapia, 74, 184–187.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol, 7, 88–95.
   PubMed Web of Science ®Google Scholar
• Fang L, Kraus B, Lehmann J, Heilmann J, Zhang Y, Decker M. (2008). Design and synthesis of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates. Bioorg Med Chem Lett, 18, 2905–2909.
   PubMed Web of Science ®Google Scholar
• Fortalezas S, Tavares L, Pimpão R, Tyagi M, Pontes V, Alves PM, McDougall G, Stewart D, Ferreira RB, Santos CN. (2010). Antioxidant properties and neuroprotective capacity of strawberry tree fruit (Arbutus unedo). Nutrients, 2, 214–229.
   PubMed Web of Science ®Google Scholar
• Joyner PM, Cichewicz RH. (2011). Bringing natural products into the fold - exploring the therapeutic lead potential of secondary metabolites for the treatment of protein-misfolding-related neurodegenerative diseases. Nat Prod Rep, 28, 26–47.
   PubMed Web of Science ®Google Scholar
• Mandel S, Amit T, Reznichenko L, Weinreb O, Youdim MB. (2006). Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders. Mol Nutr Food Res, 50, 229–234.
   PubMed Web of Science ®Google Scholar
• Mandel SA, Amit T, Weinreb O, Reznichenko L, Youdim MB. (2008). Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases. CNS Neurosci Ther, 14, 352–365.
   PubMed Web of Science ®Google Scholar
• Mohs RC, Davis BM, Johns CA, Mathé AA, Greenwald BS, Horvath TB, Davis KL. (1985). Oral physostigmine treatment of patients with Alzheimer’s disease. Am J Psychiatry, 142, 28–33.
   PubMed Web of Science ®Google Scholar
• Mukherjee PK, Kumar V, Mal M, Houghton PJ. (2007a). Acetylcholinesterase inhibitors from plants. Phytomedicine, 14, 289–300.
   PubMed Web of Science ®Google Scholar
• Mukherjee PK, Kumar V, Mal M, Houghton PJ. (2007b). In vitro acetylcholinesterase inhibitory activity of the essential oil from Acorus calamus and its main constituents. Planta Med, 73, 283–285.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. (2007). Natural products as sources of new drugs over the last 25 years. J Nat Prod, 70, 461–477.
   PubMed Web of Science ®Google Scholar
• Nordberg A, Svensson AL. (1998). Cholinesterase inhibitors in the treatment of Alzheimer’s disease: a comparison of tolerability and pharmacology. Drug Saf, 19, 465–480.
   PubMed Web of Science ®Google Scholar
• Orhan I, Kartal M, Naz Q, Ejaz A, Yilmaz G, Kan Y, Konuklugil B, Sener B, Choudhary, MI. (2007). Antioxidant and anticholinesterase evaluation of selected Turkish Salvia species. Food Chem, 103, 1247–12254.
   Web of Science ®Google Scholar
• Orhan I, Sener B, Choudhary MI, Khalid A. (2004). Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some Turkish medicinal plants. J Ethnopharmacol, 91, 57–60.
   PubMed Web of Science ®Google Scholar
• Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Lee JH, Chen S, Corpe C, Dutta A, Dutta SK, Levine M. (2003). Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr, 22, 18–35.
   PubMed Web of Science ®Google Scholar
• Perry NS, Bollen C, Perry EK, Ballard C. (2003). Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial. Pharmacol Biochem Behav, 75, 651–659.
   PubMed Web of Science ®Google Scholar
• Popova M, Bankova V, Butovska D, Petkov V, Nikolova-Damyanova B, Sabatini AG, Marcazzan GL, Bogdanov S. (2004). Validated methods for the quantification of biologically active constituents of poplar-type propolis. Phytochem Anal, 15, 235–240.
   PubMed Web of Science ®Google Scholar
• Ramassamy C. (2006). Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol, 545, 51–64.
   PubMed Web of Science ®Google Scholar
• Robards K, Antolovich M. (1997). Analytical chemistry of fruit bioflavonoids—a review. Analyst, 122, R11–R34.
   Web of Science ®Google Scholar
• Soreq H, Seidman S. (2001). Acetylcholinesterase–new roles for an old actor. Nat Rev Neurosci, 2, 294–302.
   PubMed Web of Science ®Google Scholar
• Tavares L, Carrilho D, Tyagi M, Barata D, Serra AT, Duarte CM, Duarte RO, Feliciano RP, Bronze MR, Chicau P, Espírito-Santo MD, Ferreira RB, dos Santos CN. (2010a). Antioxidant capacity of Macaronesian traditional medicinal plants. Molecules, 15, 2576–2592.
   PubMed Web of Science ®Google Scholar
• Tavares L, Fortalezas S, Carrilho C, McDougall GJ, Stewart D, Ferreira RB, Santos CN. (2010b). Antioxidant and antiproliferative properties of strawberry tree tissues. J Berry Res, 1, 3–12.
   Google Scholar
• Thanvi BR, Lo TC. (2004). Update on myasthenia gravis. Postgrad Med J, 80, 690–700.
   PubMed Web of Science ®Google Scholar
• Williams P, Sorribas A, Howes MJ. (2011). Natural products as a source of Alzheimer’s drug leads. Nat Prod Rep, 28, 48–77.
   PubMed Web of Science ®Google Scholar
• Wimo A, Jonsson L, Gustavsson A, McDaid D, Ersek K, Georges J, Gulacsi L, Karpati K, Kenigsberg P, Valtonen H.(2011). The economic impact of dementia in Europe in 2008-cost estimates from the eurocode project. Int J Geriatr Psych, DOI: 10. 1002/gps. 2610.
   Web of Science ®Google Scholar